Renowned Speakers

Kakil Ibrahim Rasul

National Center for Cancer Care and Research, Qatar Qatar

Karlo Fidel

Cardinal Santos Medical Center, Philippines Philippines

Phung Thi Huyen

Vietnam National Cancer Hospital, Vietnam Vietnam

Wassil Nowicky

Ukrainian Anti-Cancer Institute, Austria Austria

Jae Pil Hwang

Soonchunhyang University Hospital South Korea

Bo Yuan

Tokyo University of Pharmacy & Life Sciences Japan

Kirsty Hamilton

Sir Charles Gairdner Hospital Australia

Chiung-Fang Chang

Far Eastern Memorial Hospital Taiwan

Recommended Global Oncology & Cancer Webinars & Conferences

Europe & UK

Cancer Meeting Summit 2024, France Breast Pathology 2024, Italy Cancer Science 2024, Italy RADIOLOGY AND ONCOLOGY 2024, France Oncology 2024, Switzerland

Asia Pacific & Middle East

World Cancer 2024, UAE

Canada

Cancer Biology 2024, UK

Oncopathology 2019

About Oncopathology 2019

Conference Series is truly delighted to announce 13^thWorld Congress on Oncology and Pathology(Oncopathology Conference 2019) which is going to be held on November 25-26, 2019 at Helsinki, Finland. Oncopathology Conference 2019 revolves around the theme "Treatment approaches in Pathology and Diagnostic in Cancer".

Oncology:

Oncology is the term used for the study of the cancer and it is branch of medicine. Doctor who specializes in the Oncology is known as Oncologist. The vital role of the oncologist is to diagnose the people who are suffering from the cancer and explain the effects during the treatment. There are different types of Oncologists in treating the cancer. Medical Oncologist treats the cancer with the chemotherapy process. Surgical Oncologist involves in the removal of the tumor and the surrounded tissue during the surgery. Radiation Oncologist used to treat the cancer with the Radiation therapy. The Cancer is a common term for a large group of diseases that can affect any organ in the body. Other terms used are malignant tumors and neoplasms. One of the significant features of cancer is rapid creation of abnormal cells that grow beyond their usual margins, and which can then attack the adjoining parts of the body and spread to other organs. This process is referred to as metastasis. They are the major cause of death to cancer. Tobacco use, alcohol use, unhealthy diet and physical inactivity are the main cancer risk factors worldwide. Chronic infections from hepatitis B (HBV), hepatitis C virus (HCV) and some types of Kaposi’s sarcoma are leading risk factors for cancer in low- and middle-income countries.

Pathology:

Pathology is the medical specialty concerned with the study of nature and causes of diseases. In every aspect of medicine, from diagnostic testing and monitoring of chronic diseases to cutting-edge genetic research and blood transfusion technologies. Pathology is the integral to diagnosis of every cancer. Pathology is the study of the causes and effects of disease. Pathology is the study of disease in general, incorporating a wide range of bioscience research fields and medical practices. The causes and effects of diseases, especially the branch of medicine that deals with the laboratory examination of samples of body tissue for diagnostic it is also subdivided into internal and external, or medical and surgical pathology. Departments are nosology, etiology, morbid anatomy, symptomatology, and therapeutics, which treat respectively of the classification, causation, organic changes, symptoms, and cure of diseases. Cellular pathology, a theory that gives the vital action of cells in the healthy and diseased function of the body.

Some important branches of pathology:

Anatomical Pathology:

The area of pathology involves the examination of surgical specimens removed from the body or sometimes the examination of the whole body to investigate and diagnose disease. On examining a biopsy, the following aspects are considered

Gross anatomical makeup of the sample
Microscopic appearance of cells
Chemical signatures in the sample

Surgical Pathology:

This involves the examination of specimens obtained during surgery such as a breast lump biopsy obtained during mastectomy

Histopathology:

This refers to the examination of cells under a microscope after they have been stained Molecular pathology is a multi-disciplinary field that focuses on disease at the sub microscopic, molecular level. Aspects studied may include a mixture of anatomical pathology, clinical pathology, genetics, molecular biology and biochemistry. Appropriate dyes

Cytopathology:

Cytopathology cells that have been shed into bodily fluids or obtained by scraping or aspirating tissue are examined. Typical examples include cervical smear, sputum and gastric washings.

Clinical pathology:

Branch of pathology involves the laboratory analysis of body fluids such as blood, urine or cerebrospinal fluid and body tissue for the diagnosis of disease. Some of the main subspecialties of clinical pathology include:

Chemical pathology, also called clinical chemistry, involves the assessment of various components in bodily fluids such as the blood or urine, although for the main part it concerns the analysis of blood serum and plasma.

Molecular Pathology:

Molecular pathology is a multi-disciplinary field that focuses on disease at the sub microscopic, molecular level. Aspects studied may include a mixture of anatomical pathology, clinical pathology, genetics, molecular biology and biochemistry.

Why to attend Oncopathology 2019

Oncology and Pathology conference provide clinicians, scientists and students of Oncology with a knowledge transfer platform. The speakers and delegates come from academia, industries, private and government laboratories across the world.

Your attendance at Oncopathology 2019 will be a rewarding experience and we look forward to welcoming you Oncopathology knowledge transfer platform of highly updated and relevant information to a broad audience in oncology, radiology and related specialists in the field through keynote, oral, poster presentations, workshops, symposia.

Benefits in Oncopathology 2019

Oncologists working in the area of various Organ Specific Cancers like: Breast Cancer, Colorectal Cancer, Colon Cancer, Brain tumours, blood cancers, urological cancer, lung cancer specialists etc. The Cancer Experts to be gather here are basically from industry, hospitals, cancer centres and academia with the aim to discuss the current issues, trends including future innovations and strategies in the broad arena of Cancer research.

The scope of conference covers all fields of cancers. The sessions are designed in such a way that, it will cover the current trends and challenges in the Diagnosis, treatment and management of all cancer types, but not limited to Acute Lymphoblastic Leukaemia (ALL), Acute Myeloid Leukaemia (AML)

Oncologists Research in Cancer coordinates towards tending to main issues as well as future strategies of Cancer. This will be the biggest and most encouraging universal gathering where the program incorporates Clinical Oncologists, Registered Nurses, Nurse specialists and the whole restorative group required in patient care, scientists, proficient, early profession people who wish to learn standards of tumor immunology and immunotherapy well as leaders will come to examine on different parts of challenges, risks and investment opportunities of Cancers.

Oncopathologists research will manage, Cancer Prevention , Diagnosis, and Treatment of illnesses of the Organ-related Cancers and its inventive strategies.

Conference Opportunities at Oncopathology 2019

For Researchers and Faculty Members:

Speaker Presentations

Poster Display

Workshop organizing

For Universities, Associations & Societies:

Association Partnering

Collaboration proposals

Academic Partnering

Group Participation

For Business Delegates:

Speaker Presentations

Symposium hosting

Book Launch event

Networking opportunities

Audience participation

For Students and Research Scholars:

Poster Competition

Young Researcher

Student Attendee

Group Registrations

Scientific Sessions

Track 1: Oncopathology

The word cancer indicates almost 200 unique diseases that begin when a part of the body gets abnormal, developing and multiplying rapidly. Cells develop a gap to produce more cells just when the body needs them. Sometimes the cells get separated when the new cells are not required. These additional cells can be the shape of a mass of tissue, called a tumor. A tumor might be generous-harmful or carcinogenic. Unlike normal cells, cancerous cells continuously divide with no control. They don't self-destruct or die when they get to be exhausted Cancer cells affect solid cells and stop them from doing their occupations. They can attack nearby tissues or spread too far in the body to make new tumors, a procedure called metastasis.

Malignant and non-malignant tumors
Metastasis
Tumorigenesis
Carcinogenesis
Biopsy
Oncosurgery

Related Conferences:

17^th Asia Pacific Pathology Congress, August 21-22, 2019, Singapore; 18^th International Conference on Pathology & Cancer Epidemiology, October 21-22, 2019, Rome, Italy; 3^rd International Conference on Pathology and Oncology Research, November 11-22-2019, Singapore

Track 2: Breast Pathology

Breast cancers can be divided into two main overarching groups: the carcinomas and sarcomas. Carcinomas are cancers that arise from the epithelial component of the breast. This epithelial component consists of the cells that line the lobules and terminal ducts; under normal conditions, these epithelial cells are responsible for making milk. Carcinomas are majority of all breast cancers, Sarcomas are rare cancers that causes from the connective tissue components of the breast. These connective tissue component cells include myofibroblasts and blood vessel cells, and cancers arising from these "supportive" cells include phyllodes tumours and angiosarcoma. Sarcomas account for less than 1% of primary Breast Cancers.

Related Conferences:

5^th International Conference on Oncology and Research, July 25-26-2019, Italy, Rome; International Oncology Conference in Oncology, Dermatology, September 26-27-2019, USA, Chicago; 29^th Annual Mayo Clinic Hematology/Oncology Reviews 2019, August 1-3-2019, Amelia Island, FL US

Track 3: Pulmonary Pathology

Pulmonary pathology is the subspecialty of surgical pathology which deals with the diagnosis and characterization of neoplastic and non-neoplastic diseases of the lungs and thoracic pleura. Every breath that a human takes brings the outside world into the body in the form of infectious agents, organic and inorganic particles, and noxious agents of all types. Pulmonary pathology is associated with primary biliary cirrhosis includes lymphocytic bronchitis and bronchiolitis, The diagnosis of inflammatory or fibrotic diseases of the lungs is considered by many pathologists to be particularly challenging.

Related Conferences:

2^nd International Conference on Pathology and Surgical Pathology, Paris, France, July 5-6- 2019; International Conference on Medical Pathology, February 17- 19-2020, Houston; International Conference on Digital Pathology Paris, France November 19 - 20, 2020

Track 4 : Surgical pathology

Surgical pathology is the study of tissues removed from living patients during surgery to help diagnose a disease and determine a treatment plan. Often, the surgical pathologist provides consultation services in a wide variety of organ systems and medical subspecialties. Surgical pathologists give symptomatic data conclusions. Case in point, when performing breast cancer surgery, a surgical pathologist's examination of tissues separated during the surgery can help the specialist to figure out the evacuate lymph nodes under the arm, also. Surgical pathology incorporates both the physical examination of the tissue with the bare eye, and inspecting handled tissue under a magnifying instrument.

Surgical resections
Endocrine pathology
Ophthalmic pathology
Gynecologic pathology
Renal pathology

Related Conferences:

17^th Asia Pacific Pathology Congress, August 21-22, 2019, Singapore; 18^thConference on Pathology & Cancer Epidemiology October 21-22, 2019, Rome, Italy; 3^rd International Conference on Pathology and Oncology Research, November 11-22-2019, Singapore

Track 5 : Oral and Maxillofacial Pathology

Pathology includes investigating oral growths, injuries in the mouth to identify the sicknesses of the mouth, jaws, and related structures like facial muscles, salivary organ, temporomandibular joints, and perioral skin (the skin around the mouth). Dental X-rays provides some non-invasive and painless methods for identifying cavities in teeth. The world Dental Market is supposed to cross US$ 60 Billion by the year 2024.

Speech pathology
Salivary gland pathology
Periodontal diseases
Soft-tissue pathology
Epithelial pathology

Related Conferences:

Track 6 : Bone and Soft Tissue pathology

Pathology The Bone and Soft Tissue Pathology Unit of the Department of Pathology and Cell Biology deals with neoplasms and other pathological conditions that affect the skeletal system and many non-epithelial extra skeletal tissues, such as fibrous and adipose tissue, skeletal muscle, vessels, and peripheral nerves. Bone Pathology is one of the sub specialties of surgical pathology which manages the portrayal and conclusion of diagnosis of neoplastic the diagnostic process includes but is not limited to the study of the macroscopic and microscopic features of a specimen; in select cases, the diagnosis is validated by special techniques such as immunohistochemistry, cytogenetics, and molecular pathology.

Related Conferences:

Track 7 : Cytopathology

Cytopathology is a branch which deals with the study of individual cells from different sites of the body fluid to know the nature of the disease. The first cytopathology test is been conducted to the diagnose cervical cancer. Another important stream in the area of Surgical Pathology other than histopathology is Cytopathology

Exfoliative cytology
Aspiration cytology
Intervention cytology
Gynecologic cytology
Respiratory cytology

Related Conferences:

Track 8 : Oncopathology cancer pathology

Oncopathology and cancer pathology is a Branch of science which deals with the study of unusual, developing and multiplying portion of the body that are termed to be tumors is Oncopathology. Basically, it is the branch of science dealing with Cancer. It helps in studying malignant and non-malignant tumors, metastasis, tumorigenesis, and carcinogenesis

Related Conferences:

5^th International Conference on Oncology and Research, July 25-26-2019, Italy, Rome; International Oncology Conference in Oncology Dermatology, September 26-27-2019, USA, Chicago; 29^th Annual Mayo Clinic Hematology/Oncology Reviews 2019, August 1-3-2019, Amelia Island, FL US

Track 9 : Clinical pathology

The Clinical Pathology is a medical specialty is concerned with the diagnosis of disease in laboratory analysis in body liquids, for example; blood, pee, and tissue homogenates or concentrates utilizing the devices of science, microbiology, hematology and sub-atomic pathology. This process requires a medicinal residency. Clinical pathologists work in close with clinical researchers such as clinical organic chemists, clinical microbiologists, therapeutic technologists, healing centers, and alluding doctors to guarantee the exactness and ideal usage of lab testing.

Macroscopic examination
Microscopic examination
Clinical chemistry
Clinical microbiology
Molecular genetics pathology

Related Conferences:

Track 10 : Pulmonary Pathology

Pulmonary pathology includes a large spectrum of both neoplastic and non-neoplastic diseases that affect the lung. Many of these are a result of the unusual relationship of the lung with the outside world. Every breath that a human takes brings the outside world into the body in the form of infectious agents, organic and inorganic particles, and noxious agents of all types. Pulmonary pathology reported in association with primary biliary cirrhosis includes lymphocytic bronchitis and bronchiolitis, OP, and chronic interstitial pneumonia, including LIP. Rare reports have also appeared describing pulmonary hemorrhage and glomerulonephritis, or microscopic polyangiitis, in individuals with primary biliary cirrhosis.

Neoplastic diseases
Non-neoplastic diseases
Auscultation
Percussion
Pathophysiology
Tuberculosis
Bronchiectasis

Related Conferences:

17^th Asia Pacific Pathology Congress, August 21-22, 2019, Singapore; 18^th Conference on Pathology & Cancer Epidemiology October 21-22, 2019, Rome, Italy; 3^rd International Conference on Pathology and Oncology Research, November 11-22-2019, Singapore

Track 11 : Chemotherapy

Chemotherapy is the most common cancer treatment Chemo uses drugs called cytotoxics to kill or slow the growth of cancer cells. Typically, cells develop gap to create more cells just when the body needs them. Sometimes cells continue separating when new cells are not required. These additional cells may shape a mass of tissue, called a growth or tumor a tumor might be generous-harmful or carcinogenic. Unlike normal cells, cancerous cells multiply with no control. They don't self-destruct or die when they get to be exhausted harmed. Cancer cells swarm out solid cells and keep them from doing their occupations.

Combination chemotherapy
Adjuvant chemotherapy
Chemotherapy regime

Related Conferences:

Track 12 : Immunotherapy

Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system.Immunotherapy is a type of biological therapy. Biological therapy is a type of treatment that uses substances made from living organisms to treat cancer.

Cellular immunotherapy
Active immunotherapy
Non-specific active immunotherapy
Specific immunotherapy

Related Conferences:

Track 13 : Radiation Therapy

Radiation therapy is commonly applied to the cancerous tumor because of its ability to control cell growth. Ionizing radiation works by damaging the DNA of cancerous tissue leading to cellular death. To spare normal tissues generally as part of cancer treatment to control or kill malignant cells and normally delivered by a linear accelerator. Radiation therapy may be curative in a number of types of cancer if they are localized to one area of the body. It may also be used as part of adjuvant therapy, to prevent tumor recurrence after surgery to remove a primary malignant tumor (for example, early stages of breast cancer). Radiation therapy is synergistic with chemotherapy, and has been used before, during, and after chemotherapy in susceptible cancers. The subspecialty of oncology concerned with radiotherapy is called radiation oncology.

Distinguish the radio sensitivity of a particular tumor
Damaging the DNA of cancerous cells
3-dimensional confirmation radiation therapy
Radio surgery

Related Conferences:

Track 14 : Harmone Therapy

Hormone therapy: Treatment of disease or symptoms with synthetic or naturally derived hormones. The term is most commonly used to describe use of medications containing both oestrogen and progestogen to reduce or stop short-term changes associated with the perimenopause. In the more general sense, hormone therapy may be used to treat some forms of cancer, taking advantage of the fact that certain cancers depend on hormones to grow. It may also be used for thyroid disorders, and illnesses associated with hormone production or use. Hormone therapy may include giving hormones to the patient or using medications that decrease the level of hormones in the body.

Related Conferences:

5^th International Conference on Oncology and Research, July 25-26-2019, Italy, Rome; International Oncology Conference in Oncology, Dermatology September 26-27-2019, USA, Chicago; 29^th Annual Mayo Clinic Hematology/Oncology Reviews 2019, August 1-3-2019, Amelia Island, FL US

Track 15 : Targeted Therapy

Targeted therapy is a special type of chemotherapy. Advantage of this therapy is differences between normal cells and cancer cells. It’s sometimes used alone, but most often other cancer treatments are used with targeted therapy. Targeted drugs can be used as the main treatment for some cancers. These drug can’t work like chemotherapy drug, they target the parts of cancer cells that make them different from other cells.

Molecular medicine
Targeted therapy for breast cancer
Targeted therapy for lung cancer
Targeted therapy for colorectal cancer

Related Conferences:

2^nd International Conference on Pathology and Surgical Pathology, Paris, France, July 5-6- 2019; International Conference on Medical Patholog February 17- 19-2020, Houston; International Conference on Digital Pathology Paris, France November 19 - 20, 2020

Track 16 : Diagnosis and Treatments for Cancer

There are so many types of cancer treatments. This type of cancer treatment that you will depend on the type of cancer you have. Some people with cancer will have only one treatment. But most people have combination treatments, such as surgery with chemotherapy and radiation therapy may also have immunotherapy, hormonotherapy

Chemotherapy
Radiation therapy
Bone marrow transplant
Immunotherapy

Related Conferences:

Track 17 : Cancer Diagnosis

Chemotherapy
Radiation therapy
Bone marrow transplant
Immunotherapy
Hormonotherapy
Myeloma

Related Conferences:

Market Analysis

Oncology Market

Cancer happens to be a leading worldwide problem, with 14million recorded new cases every year. over 0.5 million people die from cancer every year the cancer prevalence has been increasing mostly due to the increased lifespan of people. The worldwide pathology statistical surveying report gives point by point data about the business in light of the income (USD MN) for the estimate time frame. The examination study is a spellbinding investigation of this market underscoring the market drivers and restrictions that administer the general market development. The patterns and future prospects for the market are likewise incorporated into the report which gives a scholarly comprehension of the pathology business. The pathology section is a piece of the overall pharmaceutical industry. Pathology examinations are a key piece of the clinical meeting and procedural strategy with abroad investigations exhibiting that 70-80 for every penny of every single human administration decisions impacting assurance

Pathology Market

The Global Digital Pathology Market is surveyed to be $191.00 million out of 2012, and is prepared to create at a CAGR of 12% to reach $336.61 million by 2017 .

This report considers the overall mechanized pathology show over the guess time of 2013 to 2018. The business part was surveyed at $250.2 million of every 2013 and is depended upon to reach $437 million by 2018, creating at a CAGR of 11.8% from 2013 to 2018. This report covers the definition, depiction, and gauge In perspective of things, the automated pathology showcase contains scanners, examination, accumulating, and correspondence.

Why Finland?

Europe is a histopathology services market was valued at $5,583 million in 2016, and is expected to reach $8,766 million by 2023, growing at a CAGR of 6.6% from 2017 to 2023. Recent study provides that in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets. It offers a quantitative analysis from 2016 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.Europe pathology Services Market by Type of Examination - Opportunity Analysis and Industry Forecast, 2017-2023”

Target Audience at Oncopathology 2019

Oncopathology Congress 2019 is expecting the participants from all over the world in various fields of pathology. The combination of audience will give an ideal blend to justify our Theme :" Treatment Approaches in Pathology and Diagnostics in Cancer" Oncopathology Meetings welcomes all the experts in this field to explore their research and views towards the theme of this congres

Oncologists

Professors, Researchers, Students and Technical Staff from the field of Pathologists

Delegates from various industries

Directors/Co-Directors of Research based companies across Europe and US who are investing in Pathology

Healthcare Professionals Radiologis, Immunologists, Pathologists, Clinical Oncology Researchers, Clinical Oncology Researchers,Diagnostics Companies.

Oncology Researchers

Oncologists

Surgical Oncologists

Oncology Surgeon

Radiologists

Oncology Pathologists Pathologists

Immune Oncology Therapist

Nurses

Health workers Multidisciplinary Oncology Specialists

Past Conference Report

Asia Pacific Oncologists 2018

We had successfully hosted the “15^th Asia pacific Oncologists pacific meeting” during September 05-06-2018, 2018 at Tokyo, Japan. The conference was successful in bringing together renowned speakers from various reputed organizations and their paramount talks enlightened the gathering.

The pragmatic meet organized by our management received generous response from the academia, talented Keynote Speakers, Speakers, Young Researchers, Students & Business Delegates who attended from different parts of the world made their valuable contribution to make it a successful event. The conference was marked with the presence of eminent Speakers, Young Researchers, Students & Business Delegates driving the event into the path of success with thought provoking keynote& plenary presentations.

The Conference focused on recent developments in the field of Infectious Diseases and the meeting engrossed in knowledgeable discussions on Novel Subjects like:

Pathophysiology of Cancer
Neurological Cancer
Oropharyngeal Cancer
Dermatological Cancer
Blood and Bone Cancer
Lung cancer
Renal and Hepatocellular cancer
Breast Oncology
Pancreatic and Colorectal Cancer
Reproductive Cancers
Cancer Therapy
Cancer Scenario
Nursing Oncology

Keynote forum:

Wassil Nowicky, Ukrainian Anti-Cancer Institute, Austria
Kakil Ibrahim Rasul, National Center for Cancer Care and Research, Qatar
Jae Pil Hwang, Soonchunhyang University Hospital, Republic of Korea

We extend our heartiest thanks to all the Organizing Committee Members for their kind support rendered towards the success of Asia Pacific Oncologist 2018. At the same time we take the opportunity to thank all the speakers, delegates and participants for providing their valuable contribution and time for Asia Pacific Oncologist 2018

Karlo Pan Fidel, Cardinal Santos Medical Center, Philippines
Chiung-Fang Chang, Far Eastern Memorial Hospital, Taiwan
Phung Thi Huyen, Vietnam National Cancer Hospital, Vietnam
Abdulfattah Salah Fararjeh, Taipei Medical University, Taiwan
Hemish H Kania, Dr. B. Borooah Cancer Institute, India
Juan Pablo Marquez, Sonora Cancer Research Centre, USA
Mohamed Zakaria Abdel-Rahman, Menoufia University, Egypt
Manar Atoum, Hashemite University, Jordan
Dina Abdallah, Alexandria Faculty of Medicine, Egypt

With the encouragement from the excellent feedback from the participants and supporters of Asia pacific oncologist 2018, Conference Series is glad to announce “13^th world congress on Oncology and Pathology" during November 25-26, 2019 at Helsinki, Finland.

Let us meet again @ Oncopathology 2019

Past Reports Gallery